|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/7052 | |
| A61K 9/08 | |||
| A61P 31/04 | |||
| A61K 47/10 | |||
| A61K 47/26 | |||
| A61K 47/32 | |||
| A61K 47/38 | |||
| A61P 27/02 |
| (11) | Number of the document | 2211617 |
| (13) | Kind of document | T |
| (96) | European patent application number | 08796298.1 |
| Date of filing the European patent application | 2008-07-18 | |
| (97) | Date of publication of the European application | 2010-08-04 |
| (45) | Date of publication and mention of the grant of the patent | 2020-07-08 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2008/070491 |
| Date | 2008-07-18 |
| (87) | Number | WO 2009/045603 |
| Date | 2009-04-09 |
| (30) | Number | Date | Country code |
| 905854 | 2007-10-04 | US |
| (72) |
BOWMAN, Lyle, M., US
CHANDRASEKARAN, S., Kumar, US
ARCHIBALD, Roy, Duane, US
PHAM, Stephen, US
MUFSON, David, US
|
| (73) |
Sun Pharma Global FZE,
Executive Suite Y-43 P.O. Box 122304, Sharjah,
AE
|
| (54) | CONCENTRATED AQUEOUS AZALIDE FORMULATIONS |
| CONCENTRATED AQUEOUS AZALIDE FORMULATIONS |